Coopercompanies completes acquisition of generate life sciences®

San ramon, calif., dec. 17, 2021 (globe newswire) -- coopercompanies (nyse: coo) today announced it has completed the previously announced definitive purchase agreement to acquire generate life sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage (cord blood & cord tissue), for a purchase price of approximately $1.6 billion.
COO Ratings Summary
COO Quant Ranking